首页> 外文期刊>Laboratory Animals >Review of successful treatment for Helicobacter species in laboratory mice
【24h】

Review of successful treatment for Helicobacter species in laboratory mice

机译:实验室小鼠幽门螺杆菌成功治疗的综述

获取原文
获取原文并翻译 | 示例
           

摘要

Three variations of the amoxycillin-based triple therapy (amoxycillin, metronidazole and bismuth) were administered in the diet, by oral gavage or in the diet in conjunction with cross-fostering on to Helicobacter-free foster mothers to mice naturally infected with H. hepaticus and/or H. bilis. The presence of Helicobacter species was determined by polymerase chain reaction (PCR) analysis of faecal pellets. Helicobacter infection was eliminated in 50% of strains of mice treated by oral gavage; 57% of strains of mice treated by medicated diet alone and 100% of strains of mice treated with the medicated diet in conjunction with cross-fostering on to Helicobacter-free foster mothers. Eight strains of mice were successfully treated for Helicobacter infection over a two-year period. The mouse colony has been maintained Helicobacter free, as determined by PCR analysis and has remained off treatment from December 2002 to March 2005.
机译:在饮食中,通过口服管饲法或在饮食中与基于无阿霉素的寄养母亲交叉培育对自然感染肝炎的小鼠联合施用基于阿莫西林的三联疗法的三种变体(阿莫西林,甲硝唑和铋)和/或H. bilis。通过粪便颗粒的聚合酶链反应(PCR)分析确定了幽门螺杆菌的存在。经口管饲治疗的小鼠中有50%消除了幽门螺杆菌感染。单独通过药物饮食治疗的小鼠品系中有57%以及通过药物饮食与无幽门螺杆菌的寄养母亲的交叉培育相结合的小鼠品系中的100%。在两年的时间内,成功治疗了八株小鼠的幽门螺杆菌感染。通过PCR分析确定,小鼠菌落保持无幽门螺杆菌,并且从2002年12月至2005年3月一直不治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号